Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 301

1.

Intensive lifestyle changes may affect the progression of prostate cancer.

Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, Dunn-Emke S, Crutchfield L, Jacobs FN, Barnard RJ, Aronson WJ, McCormac P, McKnight DJ, Fein JD, Dnistrian AM, Weinstein J, Ngo TH, Mendell NR, Carroll PR.

J Urol. 2005 Sep;174(3):1065-9; discussion 1069-70.

PMID:
16094059
2.

Ultrasonic spectrum-analysis and neural-network classification as a basis for ultrasonic imaging to target brachytherapy of prostate cancer.

Feleppa EJ, Ennis RD, Schiff PB, Wuu CS, Kalisz A, Ketterling J, Urban S, Liu T, Fair WR, Porter CR, Gillespie JR.

Brachytherapy. 2002;1(1):48-53.

PMID:
15062187
3.

Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence.

Yossepowitch O, Dalbagni G, Golijanin D, Donat SM, Bochner BH, Herr HW, Fair WR, Russo P.

J Urol. 2003 Jan;169(1):177-81.

PMID:
12478130
4.

Role of advanced 2 and 3-dimensional ultrasound for detecting prostate cancer.

Balaji KC, Fair WR, Feleppa EJ, Porter CR, Tsai H, Liu T, Kalisz A, Urban S, Gillespie J.

J Urol. 2002 Dec;168(6):2422-5.

PMID:
12441931
5.
6.

Introduction--translational research trends: urologic gene therapy.

Gong MC, Fair WR.

Mol Urol. 2000 Summer;4(2):37-8. No abstract available.

PMID:
12006237
7.

Spectrum-analysis and neural networks for imaging to detect and treat prostate cancer.

Feleppa EJ, Ennis RD, Schiff PB, Wuu CS, Kalisz A, Ketterling J, Urban S, Liu T, Fair WR, Porter CR, Gillespie JR.

Ultrason Imaging. 2001 Jul;23(3):135-46.

PMID:
11958585
8.

Growth of heterotopic LNCaP prostate cancer tumor in nude mice is not affected by dietary calcium.

Balaji KC, Huryk RF, Verhulst S, Fair WR.

Prostate. 2001 Sep 15;48(4):265-73.

PMID:
11536306
9.

Overview consensus statement.

Carroll PR, Fair WR, Grossfeld GD, Heston WD, Lieberman R, Malkowicz SB, Stricker HJ, Sylvester J, Peehl DM, Meyer F, Hart C.

Urology. 2001 Aug;58(2 Suppl 1):1-4. No abstract available.

PMID:
11502434
10.

Perspectives on prostate cancer diagnosis and treatment: a roundtable.

Brawer MK, Stamey TA, Fowler J, Droller M, Messing E, Fair WR.

Urology. 2001 Aug;58(2):135-40.

PMID:
11489681
11.

Partial cystectomy during radical surgery for nonurological malignancy.

Weinstein RP, Grob BM, Pachter EM, Soloway S, Fair WR.

J Urol. 2001 Jul;166(1):79-81.

PMID:
11435828
12.

Dietary trial in prostate cancer: Early experience and implications for clinical trial design.

Ornish DM, Lee KL, Fair WR, Pettengill EB, Carroll PR.

Urology. 2001 Apr;57(4 Suppl 1):200-1.

PMID:
11295627
13.

Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer.

Garnick MB, Fair WR, Bostwick D, Debruyne F, Fourcroy J, Grignon D, Porterfield H, Sufrin G, Thrasher B, Hart C.

Mol Urol. 2000 Fall;4(3):89-92. Review. No abstract available.

PMID:
11184767
14.

Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.

Fair WR, Betancourt JE.

Mol Urol. 2000 Fall;4(3):241-8;discussion 249-50.

PMID:
11062380
15.

Three-dimensional ultrasound analyses of the prostate.

Feleppa EJ, Fair WR, Liu T, Kalisz A, Balaji KC, Porter CR, Tsai H, Reuter V, Gnadt W, Miltner MJ.

Mol Urol. 2000 Fall;4(3):133-9;discussion 141.

PMID:
11062367
16.
17.

Historical perspective on prostate brachytherapy.

Garzotto M, Fair WR.

J Endourol. 2000 May;14(4):315-8.

PMID:
10910145
18.

Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies.

Gschwend JE, Fair WR, Vieweg J.

Eur Urol. 2000 Aug;38(2):121-30. Review.

PMID:
10895001
19.

Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.

Horiguchi Y, Larchian WA, Kaplinsky R, Fair WR, Heston WD.

Gene Ther. 2000 May;7(10):844-51.

20.

Progress in Two-Dimensional and Three-Dimensional Ultrasonic Tissue-Type Imaging of the Prostate Based on Spectrum Analysis and Nonlinear Classifiers.

Feleppa EJ, Fair WR, Tsai H, Porter C, Balaji KC, Liu T, Kalisz A, Lizzi FL, Rosado A, Manolakis D, Gnadt W, Reuter V V, Miltner MJ.

Mol Urol. 1999;3(3):303-310.

PMID:
10851337
21.
22.

Fourth International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer: Overview Consensus Statement.

Garnick MB, Fair WR, Goldenberg SL, Gleave M, Grignon D, Fourcroy J, Sufrin G, Porterfield H, Hart C.

Mol Urol. 1999;3(3):171-174. No abstract available.

PMID:
10851320
24.

Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.

Simak R, Capodieci P, Cohen DW, Fair WR, Scher H, Melamed J, Drobnjak M, Heston WD, Stix U, Steiner G, Cordon-Cardo C.

Histol Histopathol. 2000 Apr;15(2):365-74.

PMID:
10809354
25.
26.

Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance.

Balaji KC, Rabbani F, Tsai H, Bastar A, Fair WR.

J Urol. 1999 Sep;162(3 Pt 1):753-7.

PMID:
10458359
27.

Willet F. Whitore, Jr. Lecture: back to the future--the role of complementary medicine in urology.

Fair WR.

J Urol. 1999 Aug;162(2):411-20. Review. No abstract available.

PMID:
10411049
28.

Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice.

Fleshner N, Fair WR, Huryk R, Heston WD.

J Urol. 1999 May;161(5):1651-4.

PMID:
10210433
29.

The impact of primary stage on survival in patients with lymph node positive bladder cancer.

Vieweg J, Gschwend JE, Herr HW, Fair WR.

J Urol. 1999 Jan;161(1):72-6.

PMID:
10037372
30.
32.

Pelvic lymph node dissection can be curative in patients with node positive bladder cancer.

Vieweg J, Gschwend JE, Herr HW, Fair WR.

J Urol. 1999 Feb;161(2):449-54.

PMID:
9915424
33.

[Incidence and clinical significance of false-negative sextant biopsies of the prostate].

Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR.

Urologe A. 1998 Nov;37(6):660. German. No abstract available.

PMID:
9887497
34.

Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene.

O'Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, Zandvliet D, Russell PJ, Molloy PL, Nowak NJ, Shows TB, Mullins C, Vonder Haar RA, Fair WR, Heston WD.

Biochim Biophys Acta. 1998 Nov 26;1443(1-2):113-27.

PMID:
9838072
35.

Combating prostate cancer.

Garnick MB, Fair WR.

Sci Am. 1998 Dec;279(6):74-83. No abstract available.

PMID:
9828467
36.

Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.

Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, Herr H, Kim N, Moore MA.

Clin Cancer Res. 1997 Sep;3(9):1593-8.

37.
39.

Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors.

Perrotti M, Rabbani F, Russo P, Solomon MC, Fair WR.

Urology. 1998 Jul;52(1):106-10.

PMID:
9671879
40.

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE, Venkatramen ES, Reuter VE, Fair WR, Ling CC, Fuks Z.

Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):491-500.

PMID:
9635694
41.

Incidence and clinical significance of false-negative sextant prostate biopsies.

Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR.

J Urol. 1998 Apr;159(4):1247-50.

PMID:
9507846
42.

Clinical stage I testis cancer: long-term outcome of patients on surveillance.

Sogani PC, Perrotti M, Herr HW, Fair WR, Thaler HT, Bosl G.

J Urol. 1998 Mar;159(3):855-8.

PMID:
9474168
43.

Cancer of the prostate: a nutritional disease?

Fair WR, Fleshner NE, Heston W.

Urology. 1997 Dec;50(6):840-8. Review.

PMID:
9426711
44.
45.

Radical cystectomy in the octogenarian.

Stroumbakis N, Herr HW, Cookson MS, Fair WR.

J Urol. 1997 Dec;158(6):2113-7. Review.

PMID:
9366325
46.

Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experience.

Fair WR, Scher HI.

Surg Oncol Clin N Am. 1997 Oct;6(4):831-46. Review.

PMID:
9309096
47.

Prostatic tumor implantation in the nude mouse via a perineal approach.

Garzotto M, Huryk R, Fair WR, Heston WD.

Prostate. 1997 Sep 15;33(1):60-3.

PMID:
9294628
48.

Ureteral carcinoma in situ at radical cystectomy: does the margin matter?

Silver DA, Stroumbakis N, Russo P, Fair WR, Herr HW.

J Urol. 1997 Sep;158(3 Pt 1):768-71.

PMID:
9258077
49.

Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate.

Fleshner NE, O'Sullivan M, Fair WR.

J Urol. 1997 Aug;158(2):505-8; discussion 508-9.

PMID:
9224334
50.

Prostate-specific membrane antigen.

Fair WR, Israeli RS, Heston WD.

Prostate. 1997 Jul 1;32(2):140-8. Review.

PMID:
9215402

Supplemental Content

Support Center